Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART. [electronic resource] by
- Chiappetta, S
- Ripa, M
- Galli, L
- Razzari, C
- Longo, V
- Galli, A
- Faioni, E M
- Nozza, S
- Lazzarin, A
- Tambussi, G
Producer: 20170223
In:
The Journal of antimicrobial chemotherapy vol. 71
Availability: No items available.
|
|
6.
|
Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial. [electronic resource] by
- Ripa, M
- Pogliaghi, M
- Chiappetta, S
- Galli, L
- Pensieroso, S
- Cavarelli, M
- Scarlatti, G
- De Biasi, S
- Cossarizza, A
- De Battista, D
- Malnati, M
- Lazzarin, A
- Nozza, S
- Tambussi, G
Producer: 20160804
In:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. 21
Availability: No items available.
|
|
7.
|
Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study. [electronic resource] by
- Nozza, S
- Galli, L
- Antinori, A
- Chiappetta, S
- Mazzotta, F
- Zaccarelli, M
- Ottou, S
- De Battista, D
- Pogliaghi, M
- Di Pietro, M
- Malnati, M
- Ripa, M
- Bonora, S
- Lazzarin, A
Producer: 20160727
In:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. 21
Availability: No items available.
|